Tag - ABVC

Developments

ABVC announces joint effort with AiBtl for new clinical study on depression in cancer patients using AI

ABVC BioPharma (NASDAQ:ABVC) announced plans for a new clinical study in collaboration with AiBtl BioPharma on depression in cancer patients by integrating AI-driven solutions. The new study follows successful Phase II...

July 9, 2024

Markets

Maxim starts ABVC BioPharma at buy; PT $3

Maxim Group initiated coverage of ABVC BioPharma (NASDAQ:ABVC) with a “buy” rating and price target of $3. The stock closed at 96 cents on June 16. ABVC is developing assets in ophthalmology, mental health, and oncology...

June 17, 2022

Tag - ABVC

ABVC announces joint effort with AiBtl for new clinical study on depression in cancer patients using AI

Maxim starts ABVC BioPharma at buy; PT $3

General

More